The use of glutaraldehyde-preserved heterologous pericardium for pericardial closure after open heart surgery appears safe and maintains structural integrity without adverse tissue reactions.
Answers are grounded in this paper and cite their sources.
May support heterologous pericardial patches for closure; Level 5 data leave open need for controlled trials before practice change.
A limited series of 58 patients had their pericardial cavity closed with a patch of heterologous glutaraldehyde-preserved pericardium. No patients have been lost to follow-up, which extends between 3 hours and 50 months with a mean of 21 months. No problems related to the patch have been detected. Nine specimens have been available for macroscopic examination and 5 for microscopic study with a maximum postimplant time of 6 months. The patch maintained its initial structure, remained acellular and offered a retrosternal and intrapericardial plane of cleavage.
No takes yet. Share an insight, caveat, or question.
Gallo et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: